TechCrunch Disrupt Battlefield 2023 winner, BioticsAI, announced on Monday that it has received FDA clearance for its AI software that helps detect fetal abnormalities in ultrasound images.
BioticsAI, which won Disrupt’s Battlefield competition in 2023, gains FDA approval for its AI-powered fetal ultrasound product
Published 9 hours ago
Source: techcrunch.com
Categories
Biotech & HealthStartupsDisruptBattlefieldmedtech
Related Articles from techcrunch.com
6 hours ago
Here are the 55 US AI startups that raised $100M or more in 2025
8 hours ago
Rogue agents and shadow AI: Why VCs are betting big on AI security
8 hours ago
Well, there goes the metaverse!
9 hours ago
Looking ahead to 2026: What’s next for Startup Battlefield 200
1 day ago
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT
1 day ago